By www.reliableresearchiq.com
Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status And Forecast 2023-2027 Story
105
$ 3900
Nonalcoholic Steatohepatitis (NASH) Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AstraZeneca Arena Pharmaceuticals GSK Novo Nordisk Roche Vivus Arisaph Pharmaceuticals Cempra Pharmaceuticals Galectin Therapeutics Galmed Pharmaceuticals Genfit Gilead